ESC 365 - Head to head comparison of semaglutide and colchicine for treating atrial remodeling in post-MI rats with reduced ejection fraction

ESC2025 Premium Access

Head to head comparison of semaglutide and colchicine for treating atrial remodeling in post-MI rats with reduced ejection fraction

Session: New perspectives in cardiology (1) - Advances in mechanisms, genetic insights, and therapeutic strategies for atrial fibrillation and atrial remodelling

Topic: Arrhythmias

Speaker: Doctor Y. Etzion (Beer Sheva, IL)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Yoram Etzion

Ben-Gurion University of the Negev, Beer Sheva (Israel)

0 follower

8 more presentations in this session

Discussant - Advances in mechanisms, genetic insights, and therapeutic strategies for atrial fibrillation and atrial remodelling

Disrupted circadian rhythm in sleep disordered breathing promotes atrial fibrillation in human myocardium

Speaker: Doctor P. Hegner (Regensburg, DE)

Nation-wide GWAS meta-analysis reveals new genetic locus for early-onset atrial fibrillation

Speaker: Doctor M. Mattingsdal (Gjettum, NO)

The KCNN3 rs13376333 risk variant reduces the SK-current density in isogenic stem cell-derived and native human atrial myocytes

Speaker: Doctor V. Jimenez Sabado (Barcelona, ES)

Epicardial adipose tissue drives to macrophages response during the atrial cardiomyopathy

Speaker: Mrs N. Suffee (Paris, FR)

Access the full session

New perspectives in cardiology (1) - Advances in mechanisms, genetic insights, and therapeutic strategies for atrial fibrillation and atrial remodelling

Speakers: Doctor Y. Etzion, Doctor P. Hegner, Doctor M. Mattingsdal, Doctor V. Jimenez Sabado, Mrs N. Suffee

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources